Zhang group identifies gene that may make TNBC cells vulnerable to existing

(University of Notre Dame) A new study by University of Notre Dame researcher Siyuan Zhang and collaborators, published in Nature Communications, shows that an existing, FDA-approved drug that treats other types of breast cancer may work for TNBC.

https://www.eurekalert.org/pub_releases/2019-07/uond-zgi072319.php

Source: EurekAlert! - Biology - July 23, 2019 Category: Biology Source Type: news